Pinnacle Associates’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.3K | Hold |
12,903
| – | – | ﹤0.01% | 845 |
|
|
2025
Q1 | $11.8K | Hold |
12,903
| – | – | ﹤0.01% | 823 |
|
|
2024
Q4 | $20.5K | Hold |
12,903
| – | – | ﹤0.01% | 832 |
|
|
2024
Q3 | $73.9K | Hold |
12,903
| – | – | ﹤0.01% | 786 |
|
|
2024
Q2 | $21.2K | Hold |
12,903
| – | – | ﹤0.01% | 810 |
|
|
2024
Q1 | $66.3K | Hold |
12,903
| – | – | ﹤0.01% | 821 |
|
|
2023
Q4 | $73.9K | Hold |
12,903
| – | – | ﹤0.01% | 800 |
|
|
2023
Q3 | $61.7K | Hold |
12,903
| – | – | ﹤0.01% | 795 |
|
|
2023
Q2 | $54.8K | Hold |
12,903
| – | – | ﹤0.01% | 804 |
|
|
2023
Q1 | $68.5K | Hold |
12,903
| – | – | ﹤0.01% | 756 |
|
|
2022
Q4 | $81K | Hold |
12,903
| – | – | ﹤0.01% | 740 |
|
|
2022
Q3 | $136K | Hold |
12,903
| – | – | ﹤0.01% | 711 |
|
|
2022
Q2 | $70K | Buy |
+12,903
| New | +$70K | ﹤0.01% | 731 |
|